Cargando…
Rationale for the development of an Alzheimer’s disease vaccine
Vaccination traditionally has targeted infectious agents and thus has not heretofore been used to prevent neurodegenerative illness. However, amyloid β (Aβ) or tau, which can act like infectious proteins, or prions, might induce Alzheimer’s disease (AD). Furthermore, evidence suggests that tradition...
Autores principales: | Kwan, Ping, Konno, Haruki, Chan, Ka Yan, Baum, Larry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227628/ https://www.ncbi.nlm.nih.gov/pubmed/31526227 http://dx.doi.org/10.1080/21645515.2019.1665453 |
Ejemplares similares
-
Effects of Deferasirox in Alzheimer’s Disease and Tauopathy Animal Models
por: Kwan, Ping, et al.
Publicado: (2022) -
The Rationale for Insulin Therapy in Alzheimer’s Disease
por: Ribarič, Samo
Publicado: (2016) -
Diagnostic Tests for Alzheimer's Disease: Rationale, Methodology, and Challenges
por: Mason, S. E., et al.
Publicado: (2010) -
Alzheimer’s Disease—Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran
por: Grossmann, Klaus
Publicado: (2021) -
Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies
por: Onyango, Isaac G., et al.
Publicado: (2016)